Syros Pharmaceuticals, Inc. - Laporan Laba Rugi (TTM)

Syros Pharmaceuticals, Inc.
US ˙ OTCPK ˙ US87184Q2066

Laporan Laba Rugi (TTM)

Laporan Laba Rugi Syros Pharmaceuticals, Inc. menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
Revenue 10 15 18 20 21 23 24 25 23 15 12 9 9 10 7 4 0
Change (%) 52.42 16.22 11.26 9.58 9.83 2.72 4.62 -7.15 -36.51 -16.89 -27.84 -1.43 12.96 -29.73 -40.58 -90.70
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 25 84 112 116 170 115 108 104 96 89
Change (%) 33.22 3.21 47.41 -32.73 -5.60 -3.80 -7.36 -8.05
% of Revenue 104.32 358.55 752.31 934.21 1,908.48 1,302.46 1,088.50 1,490.22 2,323.26 22,962.95
Gross Operating Profit 10 15 18 20 21 23 -1 25 -61 -97 -103 -161 -106 -98 -97 -92 -88
Change (%) 52.42 16.22 11.26 9.58 9.83 -104.44 -2,520.13 -340.05 60.19 6.29 56.43 -34.46 -7.14 -1.17 -4.97 -4.33
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 -4.32 100.00 -258.55 -652.31 -834.21 -1,808.48 -1,202.46 -988.50 -1,390.22 -2,223.26 -22,862.95
SG&A 22 21 22 22 22 23 24 26 28 29 30 30 30 28 27 25 23
Change (%) -2.33 2.77 1.77 0.87 2.39 5.25 5.87 10.63 3.17 1.56 0.94 -1.04 -4.85 -4.03 -6.49 -8.31
% of Revenue 220.50 141.29 124.94 114.28 105.20 98.08 100.49 101.70 121.18 196.90 240.60 336.56 337.91 284.64 388.76 611.74 6,028.76
R&D 61 76 82 93 102 100 80 112 27 -58
Change (%) 24.05 7.18 13.48 10.36 -2.19 -20.05 40.69 -76.15
% of Revenue 619.23 503.98 464.77 474.05 477.45 425.20 330.91 445.00 114.33 -652.97
OpEx 83 97 103 115 125 123 129 138 139 141 145 142 144 136 131 122 112
Change (%) 17.13 6.21 11.00 8.52 -1.36 5.17 6.76 0.89 1.45 2.86 -2.21 1.56 -5.44 -3.84 -7.18 -8.10
% of Revenue 839.73 645.27 589.70 588.33 582.66 523.28 535.73 546.70 594.06 949.21 1,174.81 1,592.08 1,640.37 1,373.14 1,878.97 2,935.00 28,991.71
Operating Income -73 -82 -86 -95 -103 -99 -105 -113 -116 -126 -133 -133 -135 -126 -124 -118 -112
Change (%) 12.35 4.38 10.95 8.30 -3.68 5.75 7.25 2.69 9.13 5.19 0.17 1.76 -6.64 -1.81 -5.30 -5.19
% of Revenue -739.73 -545.27 -489.70 -488.33 -482.66 -423.28 -435.73 -446.70 -494.06 -849.21 -1,074.81 -1,492.08 -1,540.37 -1,273.14 -1,778.97 -2,835.00 -28,891.71
Interest Expense -1 -2 -2 -3 -3 -4 -4 -4 -4 -4 -4 -5 -5 -5 -5 -5 -5
Change (%) 35.45 38.84 19.45 16.49 12.85 0.23 0.26 1.73 3.51 5.83 6.81 5.37 4.12 1.76 1.99 0.17
% of Revenue -13.36 -11.87 -14.18 -15.23 -16.19 -16.63 -16.23 -15.55 -17.04 -27.78 -35.38 -52.36 -55.98 -51.60 -74.72 -128.25 -1,380.83
Net Income -74 -84 -81 -86 -93 -87 -97 -109 -114 -95 -93 -95 -105 -165 -144 -132 -98
Change (%) 14.12 -3.57 6.53 7.58 -6.80 12.61 12.30 3.86 -16.75 -1.43 1.90 10.40 56.79 -12.20 -8.95 -25.65
% of Revenue -743.66 -556.80 -462.00 -442.38 -434.30 -368.52 -404.00 -433.67 -485.12 -636.12 -754.40 -1,065.37 -1,193.32 -1,656.34 -2,069.51 -3,170.93 -25,340.67

Source: Capital IQ

Other Listings
GB:0LC7
DE:0S90
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista